In the context of pancreatic neuroendocrine tumors, CGA expression is commonly detected, with a trend indicating that tumors with metastases exhibit reduced CGA protein levels compared to those confined to the primary site (32). Here, CGA is linked to pancreatic neuroendocrine tumor.